Close
CDMO Safety Testing 2026
Novotech

Malvern Instruments’ Alan Rawle is Invited Speaker at Brian Scarlett Memorial Session at World Congress for Particle Technology

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

Dr Alan Rawle, applications manager for Malvern Instruments, has been invited to speak as part of the Brian Scarlett Memorial Session at the 7th World Congress for Particle Technology (WCPT 7), which takes place in Beijing, China, from 19-22 May.

Dr Rawle’s presentation will discuss ‘Sampling – another Cinderella of particle size analysis’ and he will highlight the importance of representative sampling for particle size analysis, explaining how to employ statistical methods to obtain accurate and reproducible results.

“Brian Scarlett was one of the most recognized, respected and effective leaders in particle technology and it is a real honor to be contributing to this memorial session,” said Alan Rawle.

“He often said that sieving or screening was the Cinderella of particle size analysis because it does the dirtiest work and attracts little attention. In my view the same statement rings true for representative sampling, so this is a fitting event at which to explore this aspect of particle sizing.”

In ‘Sampling – another Cinderella of particle size analysis’, Dr Rawle will argue that although sampling is the most common source of errors in particle sizing, frequently it does not receive enough attention. Analytical techniques including laser diffraction, dynamic light scattering and electron microscopy measure samples accurately but the results may not be representative of an entire material or product, owing to heterogeneity or variations in distribution in the bulk material. He will demonstrate how statistical methods may be used to calculate the minimum sample mass needed to meet a required level of precision, and the theoretical best achievable precision, based on the heterogeneity of the sample.

In other congress sessions, Dr Rawle will also present ‘Best practice in laser diffraction: a robustness study of the optical properties of silica.’ Here he will explore the importance of understanding the factors that can affect the particle size data generated by laser diffraction analysis and will provide guidance regarding the specific issue of optical property optimization.

Particle characterization is a central part of Malvern’s broad materials characterization portfolio, which includes analytical instruments for measuring particle size, particle shape, zeta potential, protein charge, molecular weight, mass, size and conformation, and rheological properties as well as chemical identification. These complementary analytical solutions have applications throughout industry, from pharmaceuticals and biopharmaceuticals to bulk chemicals, energy and the environment.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »